These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31168414)

  • 21. Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.
    Devauchelle-Pensec V; Berthelot JM; Cornec D; Renaudineau Y; Marhadour T; Jousse-Joulin S; Querellou S; Garrigues F; De Bandt M; Gouillou M; Saraux A
    Ann Rheum Dis; 2016 Aug; 75(8):1506-10. PubMed ID: 26929219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment.
    Belkhir R; Burel SL; Dunogeant L; Marabelle A; Hollebecque A; Besse B; Leary A; Voisin AL; Pontoizeau C; Coutte L; Pertuiset E; Mouterde G; Fain O; Lambotte O; Mariette X
    Ann Rheum Dis; 2017 Oct; 76(10):1747-1750. PubMed ID: 28600350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published Literature.
    Manzo C; Isetta M; Natale M; Castagna A
    Medicines (Basel); 2020 Nov; 7(11):. PubMed ID: 33153016
    [No Abstract]   [Full Text] [Related]  

  • 24. [Polymyalgia rheumatica: What is the current status?].
    Seitz M
    Z Rheumatol; 2015 Aug; 74(6):507-10. PubMed ID: 26169748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical management of polymyalgia rheumatica.
    Gonzalez-Gay MA; Agudo M; Martinez-Dubois C; Pompei O; Blanco R
    Expert Opin Pharmacother; 2010 May; 11(7):1077-87. PubMed ID: 20367535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature.
    Macchioni P; Boiardi L; Catanoso M; Pulsatelli L; Pipitone N; Meliconi R; Salvarani C
    Semin Arthritis Rheum; 2013 Aug; 43(1):113-8. PubMed ID: 23433960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica.
    Dejaco C; Singh YP; Perel P; Hutchings A; Camellino D; Mackie S; Matteson EL; Dasgupta B
    Ann Rheum Dis; 2015 Oct; 74(10):1808-17. PubMed ID: 26359489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group.
    Ghosh N; Couette N; van Binsbergen WH; Weinmann SC; Jivanelli B; Shea B; Bass AR; Benesova K; Bingham CO; Calabrese C; Cappelli LC; Chan KK; Choy E; Daoussis D; Goodman S; Hudson M; Jamal S; Leipe J; Lopez-Olivo MA; Suarez-Almazor M; van der Laken CJ; Meara AS; Liew D; Kostine M
    Semin Arthritis Rheum; 2023 Feb; 58():152110. PubMed ID: 36372016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective control of polymyalgia rheumatica with tocilizumab.
    Al Rashidi A; Hegazi MO; Mohammad SA; Varghese A
    J Clin Rheumatol; 2013 Oct; 19(7):400-1. PubMed ID: 24048113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT).
    Leeb BF; Bird HA; Nesher G; Andel I; Hueber W; Logar D; Montecucco CM; Rovensky J; Sautner J; Sonnenblick M
    Ann Rheum Dis; 2003 Dec; 62(12):1189-94. PubMed ID: 14644857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis, differential diagnosis and treatment of polymyalgia rheumatica.
    Nothnagl T; Leeb BF
    Drugs Aging; 2006; 23(5):391-402. PubMed ID: 16823992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment.
    Palard-Novello X; Querellou S; Gouillou M; Saraux A; Marhadour T; Garrigues F; Abgral R; Salaün PY; Devauchelle-Pensec V
    Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):773-9. PubMed ID: 26753600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of polymyalgia rheumatica usually means a favourable outcome for your patient.
    Milchert M; Brzosko M
    Indian J Med Res; 2017 May; 145(5):593-600. PubMed ID: 28948949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of criteria for polymyalgia rheumatica.
    Bird HA; Esselinckx W; Dixon AS; Mowat AG; Wood PH
    Ann Rheum Dis; 1979 Oct; 38(5):434-9. PubMed ID: 518143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of positive
    Prieto-Peña D; Martínez-Rodríguez I; Loricera J; Banzo I; Calderón-Goercke M; Calvo-Río V; González-Vela C; Corrales A; Castañeda S; Blanco R; Hernández JL; González-Gay MÁ
    Semin Arthritis Rheum; 2019 Feb; 48(4):720-727. PubMed ID: 29903537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effectiveness of a Low-dose Corticosteroid in a Patient with Polymyalgia Rheumatica Associated with Nivolumab Treatment].
    Imai Y; Tanaka M; Fujii R; Uchitani K; Okazaki K
    Yakugaku Zasshi; 2019; 139(3):491-495. PubMed ID: 30828027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
    Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series.
    Adizie T; Christidis D; Dharmapaliah C; Borg F; Dasgupta B
    Int J Clin Pract; 2012 Sep; 66(9):906-9. PubMed ID: 22897467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on treatment of polymyalgia rheumatica.
    Camellino D; Dejaco C
    Reumatismo; 2018 Mar; 70(1):59-66. PubMed ID: 29589404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of refractory polymyalgia rheumatica with etanercept: an open pilot study.
    Catanoso MG; Macchioni P; Boiardi L; Pipitone N; Salvarani C
    Arthritis Rheum; 2007 Dec; 57(8):1514-9. PubMed ID: 18050171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.